🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/02/2011 | 31,63 | 31,77 | 31,54 | 31,75 | +0,82% | 0,75% | 12.437.874 |
| 07/02/2011 | 31,43 | 31,52 | 31,24 | 31,49 | +0,33% | 0,88% | 15.175.354 |
| 04/02/2011 | 31,38 | 31,60 | 31,28 | 31,38 | -0,03% | 1,03% | 26.485.894 |
| 03/02/2011 | 31,48 | 31,57 | 31,02 | 31,39 | -2,72% | 1,76% | 42.170.367 |
| 02/02/2011 | 32,35 | 32,47 | 32,06 | 32,27 | -0,53% | 1,27% | 14.453.492 |
| 01/02/2011 | 31,81 | 32,48 | 31,39 | 32,44 | +2,50% | 3,42% | 22.434.012 |
| 31/01/2011 | 31,77 | 31,77 | 31,56 | 31,65 | +0,30% | 0,69% | 14.836.431 |
| 28/01/2011 | 31,96 | 31,99 | 31,49 | 31,56 | -0,54% | 1,58% | 16.927.191 |
| 27/01/2011 | 31,82 | 31,90 | 31,72 | 31,73 | +0,15% | 0,57% | 16.217.695 |
| 26/01/2011 | 31,88 | 32,19 | 31,66 | 31,68 | -0,48% | 1,65% | 27.418.195 |
| 25/01/2011 | 32,22 | 32,30 | 31,77 | 31,83 | -1,30% | 1,66% | 34.185.760 |
| 24/01/2011 | 32,43 | 32,43 | 32,22 | 32,25 | -0,29% | 0,65% | 20.575.908 |
| 21/01/2011 | 32,61 | 32,65 | 32,33 | 32,35 | -0,44% | 0,99% | 21.779.850 |
| 20/01/2011 | 32,25 | 32,58 | 32,18 | 32,49 | +0,41% | 1,24% | 22.645.184 |
| 19/01/2011 | 32,56 | 32,59 | 32,16 | 32,36 | +0,12% | 1,32% | 31.174.437 |
| 18/01/2011 | 32,51 | 32,73 | 31,95 | 32,32 | -1,05% | 2,41% | 61.805.800 |
| 14/01/2011 | 33,04 | 33,16 | 32,56 | 32,66 | -1,33% | 1,82% | 43.755.467 |
| 13/01/2011 | 33,96 | 34,14 | 32,93 | 33,10 | -6,62% | 3,57% | 77.860.531 |
| 12/01/2011 | 35,50 | 35,53 | 35,23 | 35,45 | +0,54% | 0,86% | 13.507.567 |
| 11/01/2011 | 35,53 | 35,61 | 35,02 | 35,26 | -0,67% | 1,66% | 10.725.861 |
| 10/01/2011 | 35,55 | 35,90 | 35,46 | 35,50 | -0,40% | 1,23% | 11.238.438 |
| 07/01/2011 | 35,47 | 35,64 | 35,17 | 35,64 | +0,78% | 1,32% | 13.365.668 |
| 06/01/2011 | 34,89 | 35,44 | 34,89 | 35,36 | +1,37% | 1,59% | 12.565.834 |
| 05/01/2011 | 34,39 | 34,90 | 34,35 | 34,89 | +0,58% | 1,61% | 15.217.274 |
| 04/01/2011 | 34,58 | 34,73 | 34,21 | 34,69 | +0,86% | 1,52% | 14.594.553 |
| 03/01/2011 | 34,63 | 35,10 | 34,34 | 34,39 | +0,00% | 2,18% | 20.498.356 |
| 31/12/2010 | 34,31 | 34,59 | 34,28 | 34,39 | +0,08% | 0,89% | 5.755.406 |
| 30/12/2010 | 34,46 | 34,54 | 34,32 | 34,36 | -0,55% | 0,64% | 5.359.158 |
| 29/12/2010 | 34,59 | 34,69 | 34,51 | 34,55 | +0,03% | 0,50% | 5.243.144 |
| 28/12/2010 | 34,70 | 34,77 | 34,45 | 34,54 | -0,08% | 0,93% | 5.679.846 |